James M. Veal
Therapeutics Clinical Research(US)Fate Therapeutics (United States)(US)
Publications by Year
Research Areas
DNA and Nucleic Acid Chemistry, Computational Drug Discovery Methods, Heat shock proteins research, Advanced biosensing and bioanalysis techniques, Angiogenesis and VEGF in Cancer
Most-Cited Works
- → Discovery of 5-[[4-[(2,3-Dimethyl-2H-indazol-6-yl)methylamino]-2-pyrimidinyl]amino]-2-methyl-benzenesulfonamide (Pazopanib), a Novel and Potent Vascular Endothelial Growth Factor Receptor Inhibitor(2008)342 cited
- → A Nucleic Acid Triple Helix Formed by a Peptide Nucleic Acid-DNA Complex(1995)296 cited
- → DAPI (4',6-diamidino-2-phenylindole) binds differently to DNA and RNA: minor-groove binding at AT sites and intercalation at AU sites(1992)272 cited
- → Oxindole-Based Inhibitors of Cyclin-Dependent Kinase 2 (CDK2): Design, Synthesis, Enzymatic Activities, and X-ray Crystallographic Analysis(2001)269 cited
- → Binding Mode of the 4-Anilinoquinazoline Class of Protein Kinase Inhibitor: X-ray Crystallographic Studies of 4-Anilinoquinazolines Bound to Cyclin-Dependent Kinase 2 and p38 Kinase(1999)233 cited
- → NMR Solution Structure of a Peptide Nucleic Acid Complexed with RNA(1994)223 cited